Cristiano Ferlini

Cristiano Ferlini

AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4399875
-
person_outline Cristiano Ferlini's MOST POPULAR ARTICLES
1-) Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patientsS Mozzetti, C Ferlini, P Concolino, F Filippetti, G Raspaglio, S Prislei, ...Clinical Cancer Research 11 (1), 298-305, 20054582005
2-) Role of microRNAs in drug-resistant ovarian cancer cellsA Sorrentino, CG Liu, A Addario, C Peschle, G Scambia, C FerliniGynecologic oncology 111 (3), 478-486, 20084402008
3-) Defining “mutation” and “polymorphism” in the era of personal genomicsR Karki, D Pandya, RC Elston, C FerliniBMC medical genomics 8, 1-7, 20152992015
4-) Glofitamab, a novel, bivalent CD20-targeting T-cell–engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma: a phase I trialM Hutchings, F Morschhauser, G Iacoboni, C Carlo-Stella, FC Offner, ...Journal of Clinical Oncology 39 (18), 1959-1970, 20213382021
5-) Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patientsG Ferrandina, GF Zannoni, E Martinelli, A Paglia, V Gallotta, S Mozzetti, ...Clinical cancer research 12 (9), 2774-2779, 20063092006